Clinical Trials Sponsored by The TIMI (Thrombolysis in Myocardial Infarction) Study Group
Total 5 results
-
AstraZenecaThrombolysis in Myocardial Infarction (TIMI) Study GroupCompletedCoronary Heart Disease (CHD)United States, Italy, Netherlands, Spain, Japan, Czechia, Hungary, Australia, Poland, Canada, United Kingdom
-
MedImmune LLCThrombolysis in Myocardial Infarction (TIMI) Study GroupCompletedST Elevation Myocardial InfarctionNetherlands, United Kingdom, Brazil, Spain, Slovakia, Israel, Czechia, Hungary, Poland, Russian Federation
-
Merck Sharp & Dohme LLCThe Thrombolysis in Myocardial Infarction Study (TIMI) GroupCompletedMyocardial Infarction | Ischemia | Peripheral Arterial Disease | Atherosclerosis | Cerebrovascular Accident
-
Merck Sharp & Dohme LLCDuke Clinical Research Institute; The TIMI (Thrombolysis in Myocardial Infarction)...CompletedMyocardial Infarction | Ischemia | Atherosclerosis | Cerebrovascular Accident
-
University of SydneyUniversity of Oslo; Imperial College London; Amgen; The Thrombolysis in Myocardial...TerminatedCardiovascular Diseases | Coronary Heart Disease | Cardiovascular Morbidity | Low-density-lipoprotein-typeUnited Kingdom, United States, Norway